ÀÚµ¿·Î±×¾Æ¿ô¾È³»
ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï±î?
ÀÚµ¿·Î±×¾Æ¿ô¾È³»
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.
½Ã°£ | ³»¿ë | 09:00 - 10:00 | µî·Ï |
---|---|
10:00 - 10:10 | °³È¸½Ä |
Session 1 | Co-chairs: Gunnar Pejler, PhD (Uppsala University) & ±èµ¿ÁØ (ÇѸ²´ë ¼Òȱ⳻°ú) |
10:10 – 10:30 | Mechanism of NF-kB Activation by ROS in Cancer Cells |
10:30 – 11:00 | Cancer and Inflammation - the Impact of Mast Cells |
11:00 - 11:20 | Control of Liver Inflammation by Modulating Intestinal Microorganisms |
11:20 - 11:50 | Fecal Transplant in Chronic IBS and IBD |
11:50 - 13:30 | Lunch |
Session 2 | Co-chairs: Lars Rönnblom, MD, PhD (Uppsala University) & ¼»ó¿ø (ÇѸ²´ë »ý¸®Çб³½Ç) |
13:30 - 14:00 | The Importance of the Interferon System in SLE |
14:00 - 14:20 | Multidisciplinary Approach to Management of Rheumatoid Arthritis Patient |
14:20 - 14:50 | Involvement of the Type I Interferon System in the Pathogenesis of Systemic Sclerosis |
14:50 - 15:10 | Clinical Characteristics and Therapeutic Approach in Dermatomyositis |
15:10 - 15:30 | Coffee Break |
Session 3 | Co-chairs: Marie Allen, PhD (Uppsala University) & ÀÌ¿µ°æ (ÇѸ²´ë Áø´Ü°Ë»çÀÇÇаú) |
15:30 - 15:50 | DNA for Molecular Pathology |
15:50 - 16:20 | Forensic DNA Testing for Crime Scene Samples and Ancient Materials |
16:20 - 16:40 | Pathophysiology of Multiple Myeloma |
16:40 - 17:00 | Æóȸ½Ä |